Comparative Analysis of Infective Endocarditis in Hemodialysis Versus Non-Hemodialysis Patients in Iran: Implications for Clinical Practice and Future Research Publisher Pubmed



Zolfaghari F¹ ; Peighambari MM² ; Kohansal E¹ ; Sadeghpour A³ ; Moradnejad P¹ ; Shafii Z¹ Show Affiliations
Source: BMC Cardiovascular Disorders Published:2024

Abstract

Background: In hemodialysis (HD) patients, there is a larger frequency of mortality and morbidity associated with infective endocarditis (IE) as opposed to the general population. Despite the increased burden of IE in the HD population, optimal strategies for prevention and management still need to be clarified. Elucidating the distinguishing features and outcomes of IE in HD patients is crucial to guide clinical decision-making and improve prognosis in this high-risk group. However, the details of IE characteristics, specifically in HD patients in the Middle East, are limited. Objective: To compare the clinical characteristics and short-term outcomes of IE between HD and non-HD patients. Methods: A retrospective analysis was carried out on 139 patients with infective endocarditis who were referred to a tertiary cardiovascular center in Iran from 2006 to 2018. The participants were split into HD (n = 34) and non-HD (n = 105) groups. Data pertaining to demographic characteristics, comorbidities, microbiological findings, occurrence of complications, therapeutic interventions, and mortality rates during hospital stay were gathered. Results: Diabetes, hypertension, and congestive heart failure were observed more frequently in HD patients. HD patients were more likely than non-HD patients to have involvement of the right valve (41.2% vs. 20.9%), larger vegetation, and extracardiac emboli. In-hospital mortality was 41.2% for HD patients versus 14.3% for non-HD patients. Mortality remained high after valve surgery in HD patients (38.2% vs. 10.5% in non-HD). Conclusion: HD patients exhibited a distinct clinical profile of IE with worse short-term outcomes, including higher mortality. © 2023, The Author(s).